ARTR™ Organ Repair
Common Questions and Answers
What are the benefits of an ARTR™ organ repair procedure?
Many types of organ diseases or failures are progressive and ultimately result in loss of the organs ability to function.
The new medical treatment, Autologous Regenerative Tissue Replacement, (ARTR™), which support the repair of kidneys, livers, lungs, and the pancreas, is a patient specific process. The tissues of the patient are collected, and medically transferred to a highly specialized medical laboratory, where the patient’s cells are grown into a strong, healthy, and aggressive disease fighting army of cells. They are assembled and grown as a unique, patient customized ARTR™. Upon completion, this new patient specific ARTR™ is medically transferred to an authorized surgical center to be implanted into the patients diseases or failing organ.
Each ARTR™ is nurtured and custom grown, there is no mass-production. Each is carefully created for each patient. Quality and perfection takes time.
What organs can be treated with an ARTR™ organ repair procedure?
Currently the new medical treatment, Autologous Regenerative Tissue Replacement, (ARTR™), has demonstrated an ability to repair kidneys, livers, lungs, and the pancreas. During 2021, each of these new ARTR™ organ repair procedures are scheduled to become available to patients.
Can anyone with an organ disease or failing organ apply for an ARTR™ organ repair procedure?
An ARTR™ organ repair procedure may not be the best medical solution for everyone. The procedure is available for many types of organ diseases and failures; however, no decision should be made without consultation with a qualified surgeon and others.
What factors are considered in approving a patient for a an ARTR™ organ repair procedure?
The patient selection procedures, and approval processes, includes many
factors and conditions. In general, the candidate patient must demonstrates the need for a regenerative organ tissue replacement procedure. Factors considered include:
1) Has a serious disease or condition, or whose life is immediately
threatened by their disease or condition.
2) Has no immediate plan or opportunity to receive an organ transplant.
3) Has previously received an animal or human organ transplant and the
procedures has failed to fully address the required solution.
4) Has no satisfactory alternative therapy for treatment of the disease,
injury or condition.
5) Has a disease, injury, or condition where the regenerative organ tissue
replacement treatment benefits justify the potential risks of the procedure.
6) Has a risk of further deterioration or degradation in quality of life.
7) Has been placed under Hospice care.
8) Has indicated an acceptance, if necessary, to travel to a foreign country to receive the procedure.
9) Has other factors which indicate a clear need for the procedure.
How does one apply for consideration to receive a an ARTR™ organ repair procedure?
The first step is to notify either BCM or the RTH Network of a desire to be considered, or to learn more, by sending a note to BCM or RTH using the contact form on the respective websites, or sending an email to: email@example.com or
Is an ARTR™ organ repair procedure an alternative to an organ transplant procedure?
For some patients, an ARTR™ organ repair procedure can be an alternative to an organ transplant. However, no decision should be made without consultation with a qualified surgeon and others.
Do you need an organ transplant? Do you have a diseased, injured, or failing organ?
The ARTR™ organ repair procedure is medical science’s newest and highly superior alternative to an organ transplant. Count on ARTR™ to bring you a better “Quality of Life.
To learn more about the ARTR™ organ repair program and procedure for these organs,
click on the organ link.
In what countries are currently offering an ARTR™ organ repair procedure?
Pakistan is the first country authorized to offer ARTR™ organ repair procedures.
Other countries are applying for rights to provide ARTR™ organ repair procedures. This response will be updated as additional countries are approved.
Medical travel visas and procedures are available to support patients from most counties to receive an ARTR™ organ repair procedures.
How long does it take for an ARTR™ organ repair procedure to deliver results? What are the four phases of the organ regeneration and the approximate timing of each phase?
In terms of the ARTR™ process these four phases are specifically defined to be:
1. Cell collection
2. Cell-tissue implanted on ARTR™
3. ARTR™ implanted into organ providing induction of in-vivo cell-tissue growth
4. Functional organ recovery.
Phase , the patient’s organ cells are collected through a standard biopsy procedure. The collected organ tissue biopsy are shipped to the BCM operated ARTR™ cell regenerative facility. These cells are carefully processed to create a patient-based organ repair ARTR™.
In phase , the customized ARTR™ is transported to the surgical implant hospital where the patient specific ARTR™ organ repair unit, with an army of newly created healthy cells, is surgically implanted into the patient’s failing or diseased organ by a highly qualified ARTR™ implant surgeon.
In phase , within the first initial minutes of surgical implant the army of new, healthy, cells, begin merging with existing organ cells. At this point an explosion of new healthy cell growth occurs, stimulated by the arrival of the implanted army of health new cells.
In phase , the final phase, new cell growth continues to begin to bring the return of health and functionality to the organ. This is basic, ARTR™ procedure stimulated, “in vitro” style, cell, and organ tissue regeneration. This is a natural growth process and can require 30 to 45 days to deliver functional organ recovery.
What is the duration and schedule of an ARTR™ organ repair procedure?
The schedule for an ARTR™ organ repair procedure requires a period of application, medical evaluation, the actual procedures and follow up monitoring. The ARTR™ processing schedule is Click Here
What is the cost of an ARTR™ organ repair procedure?
The costs of an ARTR™ organ repair procedure includes pre-procedures costs, the costs of the actual procedure, and the cost of follow up monitoring. The cost of the ARTR™ actual procedure are: Click Here
Is an ARTR™ organ repair procedures covered by US Medicare or other health insurance programs in the US or other countries?
The ARTR™ organ repair procedure is a new medical treatment. Therefore, US Medicare and the other US health insurance providers have not had the time to add the ARTR™ procedure into their systems.
However, in the case on new medical procedures, such as ARTR™, US Medicare and other US health insurance providers do allow for the submittal of claims for medical procedure reimbursement.
The Right to Heal Network (RTH), with support from BCM, for free, with the patient’s permission, will submit the forms, contact the health insurance provider, and assist in the pursuit of a reimbursement request.
In other counties, medical financial support and aid is established by the local or national government. Neither RTH or BCM have any control over those issues or healthcare programs.
There are also local, national, and international charities that address many types of organ failures and issues of the need for an organ transplant.
RTH and BCM cannot guarantee that any pursuit of a reimbursement or a request for aid for an ARTR™ organ repair procedure will be granted.
What is the relationship between BCM, the RTH Network, and Participating Countries, Hospitals, and Surgeons?
BCM Industries is a U.S. licensed pharmaceutical and industry leader in Autologous Regenerative Tissue Replacement (ARTR™) organ repair products, processes, and technologies. ARTR™ studies, and clinical trials, have has demonstrated an ability to repair kidneys, livers, lungs, and the pancreas. During 2021, each of these new ARTR™ organ repair procedures are scheduled to become available to patients.
The RTH Network is an international organization that administers the activities associated with finding, selecting, and assisting candidate patients in receiving ARTR™ organ repair procedures. RTH also administers all activities associated with the participating countries, hospitals, surgeons, and medical teams required to deliver ARTR™ organ repair treatments.